BAKX Therapeutics

We create targeted cancer therapies through unique insights into the conformationally dynamic protein drivers of the mitochondrial apoptosis pathway combined with structure-based drug design and computational simulations We have built an integrated & iterative platform based on knowledge, experimentation, and simulation that allows us to better interrogate and harness the power of regulated apoptosis We are developing a suite of orally active therapeutics which can act as single agents or in combination with other oncology therapies to create better and lasting outcomes for cancer patients

Website

http://www.bakxtx.com

External link for BAKX Therapeutics

Industry

Biotechnology

Company size

11-50 employees

Headquarters

New York | Boston

Type

Privately Held

Founded

2020

Specialties

Oncology, Apoptosis, Cell Death, Leukemias and Lymphomas, Solid tumors, Computational design, Research & Development, and Drug Discovery